Neobes en es it fr

Neobes Brand names, Neobes Analogs

Neobes Brand Names Mixture

  • No information avaliable

Neobes Chemical_Formula


Neobes RX_link

Neobes fda sheet

Neobes FDA

Neobes msds (material safety sheet)

Neobes MSDS

Neobes Synthesis Reference

No information avaliable

Neobes Molecular Weight

205.296 g/mol

Neobes Melting Point

No information avaliable

Neobes H2O Solubility

No information avaliable

Neobes State

No information avaliable

Neobes LogP


Neobes Dosage Forms

25 mg tablets and 75 mg controlled-release tablets.

Neobes Indication

Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.

Neobes Pharmacology

Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.

Neobes Absorption

Diethylpropion is rapidly absorbed from the GI tract after oral administration.

Neobes side effects and Toxicity

The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.

Neobes Patient Information

No information avaliable

Neobes Organisms Affected

Humans and other mammals